(21), demonstrating that binding of NKp44 to proliferating cell nuclear antigen (PCNA), that is overexpressed in some cancer cells, mediates NKp44/ITIM signaling, thus promoting cancer survival. The gene discussed is NCR2; the disease is cancer.